Tag: DTC


CHC Comment to FDA: Less Is More in DTC TV Ads

May 2, 2014 – The Coalition for Healthcare Communication believes that “shorter, simpler disclosures are most likely to lead to robust doctor-patient conversations and better health outcomes,” according to a comment the CHC submitted to the FDA today on its proposal to conduct research on the impact of limiting risks presented in direct-to-consumer (DTC) prescription […]

Read more

Drug Facts Literature Review: Call for Comments

Feb. 3, 2012 – There are just 10 days left to comment on an FDA draft report that explores the best way to present risk and benefit information in prescription drug ads. The draft report, “Quantitative Summary of the Benefits and Risks of Prescription Drugs: A Literature Review,” which was made public at the end of […]

Read more

Digital Advertising Alliance Launches Consumer Education Campaign

Jan. 27, 2012 – The Digital Advertising Alliance (DAA) last week launched its “Your AdChoices” public education campaign to inform consumers about interest-based advertising and how to take greater control of their online privacy. This campaign follows several years of work by industry association leaders to develop and implement cross-industry best practices and effective solutions […]

Read more

FDA Issues Draft Guidance on Unsolicited Off-label Info Requests, Addresses both Professional and Internet Media

Jan. 2, 2012 – In the waning days of 2011, the FDA released a significant draft guidance on company responses to unsolicited requests for off-label information by healthcare professionals and consumers.  Although the FDA explicitly recognized the value of company-provided information, the draft guidance  adhered to its traditional policy stance strickly limiting such answers to the individual making the request […]

Read more

CHC Executive Director Criticizes EU Ban on DTC

Oct. 14, 2011 – The European Commission’s announcement this week that it has adopted a proposal to maintain the EC’s current ban on consumer advertising for prescription drugs may have been expected, but it has industry experts in the United States scratching their heads. European Commissioner for Health John Dalli offered this rationale for the […]

Read more

Fall 2011 Update: Four Things Industry Should Know

  By John Kamp, Coalition for Healthcare Communication Executive Director Sept. 13, 2011 — Debates over health care and related marketing costs are certain to arise as the Congress and White House struggle to reduce the deficit,  stimulate the economy and prepare for the upcoming elections. Meanwhile, the IMS Supreme Court decision is causing a […]

Read more